University of Sydney (USYD)

University / College


Location: Sydney, Australia (AU) AU

ISNI: 000000041936834X

ROR: https://ror.org/0384j8v12

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A bending test protocol for characterizing the mechanical performance of flexible photovoltaics () Fukuda K, Sun L, Du B, Takakuwa M, Wang J, Someya T, Marsal LF, et al. Journal article Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease (2024) Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching P, et al. Journal article Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma (2024) Hamel AR, Yan W, Rouhana JM, Monovarfeshani A, Jiang X, Mehta PA, Advani J, et al. Journal article Effects of Instructed Laryngeal Manipulation on Vocal Rise Time (2024) Bi M, Nguyen DD, Arias Vergara T, Döllinger M, Holik J, Madill C Journal article A brave new framework for glioma drug development (2024) Hotchkiss KM, Karschnia P, Schreck KC, Geurts M, Cloughesy TF, Huse J, Duke ES, et al. Journal article, Review article Progression of Bone Marrow Lesions and the Development of Knee Osteoarthritis: Osteoarthritis Initiative Data (2024) Moradi K, Mohammadi S, Roemer FW, Momtazmanesh S, Hathaway Q, Ibad HA, Hunter DJ, et al. Journal article VOAT: Voice Onset Analysis Tool (2024) Arias Vergara T, Madill C, Nguyen D, Holik J, Döllinger M Journal article Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma (2024) Saner FA, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, et al. Journal article The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects (2024) Ertl C, Ruf T, Mentzer D, Kong M, Kramer R, Bergwelt-Baildon Mv, Subklewe M, et al. Journal article Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma. (2024) Albrecht LJ, Dimitriou F, Grover P, Hassel JC, Erdmann M, Forschner A, Johnson DB, et al. Journal article